Loading…
Use of antenatal corticosteroids for preterm birth in Latin America: providers knowledge, attitudes and practices
Antenatal corticosteroids administered to women at risk of preterm birth is an intervention which has been proved to reduce the risk of respiratory distress syndrome, intraventricular hemorrhage, and neonatal mortality. There is a significant gap in the literature regarding the prevalence of the use...
Saved in:
Published in: | Reproductive health 2013-01, Vol.10 (1), p.4-4, Article 4 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-b576t-4f0c27e7c9ec7bf6225f6e45a4480d96d9d832dad9f8a0fd47e817782c5aecc03 |
---|---|
cites | cdi_FETCH-LOGICAL-b576t-4f0c27e7c9ec7bf6225f6e45a4480d96d9d832dad9f8a0fd47e817782c5aecc03 |
container_end_page | 4 |
container_issue | 1 |
container_start_page | 4 |
container_title | Reproductive health |
container_volume | 10 |
creator | Aleman, Alicia Cafferata, Maria L Gibbons, Luz Althabe, Fernando Ortiz, Jose Sandoval, Xochitl Padilla-Raygoza, Nicolás Belizán, José M |
description | Antenatal corticosteroids administered to women at risk of preterm birth is an intervention which has been proved to reduce the risk of respiratory distress syndrome, intraventricular hemorrhage, and neonatal mortality. There is a significant gap in the literature regarding the prevalence of the use of antenatal corticosteroids in Latin American countries and the attitudes and opinions of providers regarding this practice. The aim of this study was to assess the knowledge, attitudes and practices of health care providers regarding the use of antenatal corticosteroids in women at risk of preterm birth in Latin America.
This was a multicenter, prospective, descriptive study conducted in maternity hospitals in Ecuador, El Salvador, Mexico and Uruguay. Physicians and midwives who provide prenatal care or intrapartum care for women delivering in the selected hospitals were approached using a self-administered questionnaire. Descriptive statistics was used.
The percentage of use of ACT in threatened preterm labour (TPL) reported by providers varies from 70% in Mexico to 97% in Ecuador. However, 60% to 20% of the providers mentioned that they would not use this medication in women at risk and would limit its use when there was a threatened preterm labour. In only one country recommended regimens of antenatal corticosteroids are followed by around 90% of providers whereas in the other three countries recommended regimens are followed by only 21%, 61%, 69% of providers. Around 40% of providers mentioned that they would administer a new dose of corticosteroids again, regardless the patient already receiving an entire regimen. Between 11% and 35% of providers, according to the countries, mentioned that they do not have adequate information on the correct use of this medication.
This study shows that the use of this intervention could be improved by increasing the knowledge of Latin American providers on its indications, benefits, and regimens. |
doi_str_mv | 10.1186/1742-4755-10-4 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3598882</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A534693254</galeid><sourcerecordid>A534693254</sourcerecordid><originalsourceid>FETCH-LOGICAL-b576t-4f0c27e7c9ec7bf6225f6e45a4480d96d9d832dad9f8a0fd47e817782c5aecc03</originalsourceid><addsrcrecordid>eNqNkstrFTEUxgdRbK1uXUrAjQun5jnJuBAupT7gghu7DrnJyW3qzOQ2yVT875uh9dpqBQnkcc6XHydfTtO8JPiYENW9I5LTlkshWoJb_qg53Ace39kfNM9yvsCYEYXl0-aAMtZhSdhhc3mWAUWPzFRgMsUMyMZUgo25QIrBZeRjQrsE9TiiTUjlHIUJrU2p82qEFKx5X_PxKjhIGX2f4o8B3BbeIlNKKLODXOGuSoytXMjPmyfeDBle3K5HzdnH028nn9v1109fTlbrdiNkV1rusaUSpO3Byo3vKBW-Ay4M5wq7vnO9U4w643qvDPaOS1BESkWtMGAtZkfNhxvubt6M4CxMJZlB71IYTfqpown6fmYK53obrzQTvVKKVsDqBrAJ8R-A-xkbR71YrhfLNcGaV8ab2yJSvJwhFz2GbGEYzARxzpowyhTGgrP_kBKpRKfUQn39h_Qizmmqbi4q3mNRlb9VWzOADpOPtUq7QPVKMN71jIqFdfyAqg4HY22DCXyo8Ycu2BRzTuD3jtQXLz35twev7n7EXv6rCdk10eHdWA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1314905785</pqid></control><display><type>article</type><title>Use of antenatal corticosteroids for preterm birth in Latin America: providers knowledge, attitudes and practices</title><source>Publicly Available Content Database</source><source>PubMed Central(OpenAccess)</source><creator>Aleman, Alicia ; Cafferata, Maria L ; Gibbons, Luz ; Althabe, Fernando ; Ortiz, Jose ; Sandoval, Xochitl ; Padilla-Raygoza, Nicolás ; Belizán, José M</creator><creatorcontrib>Aleman, Alicia ; Cafferata, Maria L ; Gibbons, Luz ; Althabe, Fernando ; Ortiz, Jose ; Sandoval, Xochitl ; Padilla-Raygoza, Nicolás ; Belizán, José M</creatorcontrib><description>Antenatal corticosteroids administered to women at risk of preterm birth is an intervention which has been proved to reduce the risk of respiratory distress syndrome, intraventricular hemorrhage, and neonatal mortality. There is a significant gap in the literature regarding the prevalence of the use of antenatal corticosteroids in Latin American countries and the attitudes and opinions of providers regarding this practice. The aim of this study was to assess the knowledge, attitudes and practices of health care providers regarding the use of antenatal corticosteroids in women at risk of preterm birth in Latin America.
This was a multicenter, prospective, descriptive study conducted in maternity hospitals in Ecuador, El Salvador, Mexico and Uruguay. Physicians and midwives who provide prenatal care or intrapartum care for women delivering in the selected hospitals were approached using a self-administered questionnaire. Descriptive statistics was used.
The percentage of use of ACT in threatened preterm labour (TPL) reported by providers varies from 70% in Mexico to 97% in Ecuador. However, 60% to 20% of the providers mentioned that they would not use this medication in women at risk and would limit its use when there was a threatened preterm labour. In only one country recommended regimens of antenatal corticosteroids are followed by around 90% of providers whereas in the other three countries recommended regimens are followed by only 21%, 61%, 69% of providers. Around 40% of providers mentioned that they would administer a new dose of corticosteroids again, regardless the patient already receiving an entire regimen. Between 11% and 35% of providers, according to the countries, mentioned that they do not have adequate information on the correct use of this medication.
This study shows that the use of this intervention could be improved by increasing the knowledge of Latin American providers on its indications, benefits, and regimens.</description><identifier>ISSN: 1742-4755</identifier><identifier>EISSN: 1742-4755</identifier><identifier>DOI: 10.1186/1742-4755-10-4</identifier><identifier>PMID: 23360713</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Adult ; Attitude of Health Personnel ; Attitudes ; Clinical Competence ; corticoids ; Corticosteroids ; Dosage and administration ; Drug Administration Schedule ; Drug Utilization - statistics & numerical data ; Drugs ; Female ; Glucocorticoids - administration & dosage ; Glucocorticoids - adverse effects ; Glucocorticoids - supply & distribution ; Glucocorticoids - therapeutic use ; Health aspects ; Health care industry ; Hospitals ; Humans ; Infant, Newborn ; Infant, Premature ; Infants ; Infants (Premature) ; Intervention ; Latin America ; Male ; Maternal health services ; Middle Aged ; Midwives ; Mortality ; Neonates ; Patient outcomes ; Practice Patterns, Physicians' - statistics & numerical data ; Pregnancy ; Pregnancy Complications - drug therapy ; Premature birth ; Premature Birth - drug therapy ; Prenatal Care - methods ; Prevention ; Prospective Studies ; Reproduction ; Reproductive health ; Respiratory Distress Syndrome, Newborn - prevention & control ; Womens health</subject><ispartof>Reproductive health, 2013-01, Vol.10 (1), p.4-4, Article 4</ispartof><rights>COPYRIGHT 2013 BioMed Central Ltd.</rights><rights>2013 Aleman et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright ©2013 Aleman et al.; licensee BioMed Central Ltd. 2013 Aleman et al.; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b576t-4f0c27e7c9ec7bf6225f6e45a4480d96d9d832dad9f8a0fd47e817782c5aecc03</citedby><cites>FETCH-LOGICAL-b576t-4f0c27e7c9ec7bf6225f6e45a4480d96d9d832dad9f8a0fd47e817782c5aecc03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598882/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1314905785?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23360713$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aleman, Alicia</creatorcontrib><creatorcontrib>Cafferata, Maria L</creatorcontrib><creatorcontrib>Gibbons, Luz</creatorcontrib><creatorcontrib>Althabe, Fernando</creatorcontrib><creatorcontrib>Ortiz, Jose</creatorcontrib><creatorcontrib>Sandoval, Xochitl</creatorcontrib><creatorcontrib>Padilla-Raygoza, Nicolás</creatorcontrib><creatorcontrib>Belizán, José M</creatorcontrib><title>Use of antenatal corticosteroids for preterm birth in Latin America: providers knowledge, attitudes and practices</title><title>Reproductive health</title><addtitle>Reprod Health</addtitle><description>Antenatal corticosteroids administered to women at risk of preterm birth is an intervention which has been proved to reduce the risk of respiratory distress syndrome, intraventricular hemorrhage, and neonatal mortality. There is a significant gap in the literature regarding the prevalence of the use of antenatal corticosteroids in Latin American countries and the attitudes and opinions of providers regarding this practice. The aim of this study was to assess the knowledge, attitudes and practices of health care providers regarding the use of antenatal corticosteroids in women at risk of preterm birth in Latin America.
This was a multicenter, prospective, descriptive study conducted in maternity hospitals in Ecuador, El Salvador, Mexico and Uruguay. Physicians and midwives who provide prenatal care or intrapartum care for women delivering in the selected hospitals were approached using a self-administered questionnaire. Descriptive statistics was used.
The percentage of use of ACT in threatened preterm labour (TPL) reported by providers varies from 70% in Mexico to 97% in Ecuador. However, 60% to 20% of the providers mentioned that they would not use this medication in women at risk and would limit its use when there was a threatened preterm labour. In only one country recommended regimens of antenatal corticosteroids are followed by around 90% of providers whereas in the other three countries recommended regimens are followed by only 21%, 61%, 69% of providers. Around 40% of providers mentioned that they would administer a new dose of corticosteroids again, regardless the patient already receiving an entire regimen. Between 11% and 35% of providers, according to the countries, mentioned that they do not have adequate information on the correct use of this medication.
This study shows that the use of this intervention could be improved by increasing the knowledge of Latin American providers on its indications, benefits, and regimens.</description><subject>Adult</subject><subject>Attitude of Health Personnel</subject><subject>Attitudes</subject><subject>Clinical Competence</subject><subject>corticoids</subject><subject>Corticosteroids</subject><subject>Dosage and administration</subject><subject>Drug Administration Schedule</subject><subject>Drug Utilization - statistics & numerical data</subject><subject>Drugs</subject><subject>Female</subject><subject>Glucocorticoids - administration & dosage</subject><subject>Glucocorticoids - adverse effects</subject><subject>Glucocorticoids - supply & distribution</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Health aspects</subject><subject>Health care industry</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Infant, Premature</subject><subject>Infants</subject><subject>Infants (Premature)</subject><subject>Intervention</subject><subject>Latin America</subject><subject>Male</subject><subject>Maternal health services</subject><subject>Middle Aged</subject><subject>Midwives</subject><subject>Mortality</subject><subject>Neonates</subject><subject>Patient outcomes</subject><subject>Practice Patterns, Physicians' - statistics & numerical data</subject><subject>Pregnancy</subject><subject>Pregnancy Complications - drug therapy</subject><subject>Premature birth</subject><subject>Premature Birth - drug therapy</subject><subject>Prenatal Care - methods</subject><subject>Prevention</subject><subject>Prospective Studies</subject><subject>Reproduction</subject><subject>Reproductive health</subject><subject>Respiratory Distress Syndrome, Newborn - prevention & control</subject><subject>Womens health</subject><issn>1742-4755</issn><issn>1742-4755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNkstrFTEUxgdRbK1uXUrAjQun5jnJuBAupT7gghu7DrnJyW3qzOQ2yVT875uh9dpqBQnkcc6XHydfTtO8JPiYENW9I5LTlkshWoJb_qg53Ace39kfNM9yvsCYEYXl0-aAMtZhSdhhc3mWAUWPzFRgMsUMyMZUgo25QIrBZeRjQrsE9TiiTUjlHIUJrU2p82qEFKx5X_PxKjhIGX2f4o8B3BbeIlNKKLODXOGuSoytXMjPmyfeDBle3K5HzdnH028nn9v1109fTlbrdiNkV1rusaUSpO3Byo3vKBW-Ay4M5wq7vnO9U4w643qvDPaOS1BESkWtMGAtZkfNhxvubt6M4CxMJZlB71IYTfqpown6fmYK53obrzQTvVKKVsDqBrAJ8R-A-xkbR71YrhfLNcGaV8ab2yJSvJwhFz2GbGEYzARxzpowyhTGgrP_kBKpRKfUQn39h_Qizmmqbi4q3mNRlb9VWzOADpOPtUq7QPVKMN71jIqFdfyAqg4HY22DCXyo8Ycu2BRzTuD3jtQXLz35twev7n7EXv6rCdk10eHdWA</recordid><startdate>20130129</startdate><enddate>20130129</enddate><creator>Aleman, Alicia</creator><creator>Cafferata, Maria L</creator><creator>Gibbons, Luz</creator><creator>Althabe, Fernando</creator><creator>Ortiz, Jose</creator><creator>Sandoval, Xochitl</creator><creator>Padilla-Raygoza, Nicolás</creator><creator>Belizán, José M</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7U1</scope><scope>7U2</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>20130129</creationdate><title>Use of antenatal corticosteroids for preterm birth in Latin America: providers knowledge, attitudes and practices</title><author>Aleman, Alicia ; Cafferata, Maria L ; Gibbons, Luz ; Althabe, Fernando ; Ortiz, Jose ; Sandoval, Xochitl ; Padilla-Raygoza, Nicolás ; Belizán, José M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b576t-4f0c27e7c9ec7bf6225f6e45a4480d96d9d832dad9f8a0fd47e817782c5aecc03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Attitude of Health Personnel</topic><topic>Attitudes</topic><topic>Clinical Competence</topic><topic>corticoids</topic><topic>Corticosteroids</topic><topic>Dosage and administration</topic><topic>Drug Administration Schedule</topic><topic>Drug Utilization - statistics & numerical data</topic><topic>Drugs</topic><topic>Female</topic><topic>Glucocorticoids - administration & dosage</topic><topic>Glucocorticoids - adverse effects</topic><topic>Glucocorticoids - supply & distribution</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Health aspects</topic><topic>Health care industry</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Infant, Premature</topic><topic>Infants</topic><topic>Infants (Premature)</topic><topic>Intervention</topic><topic>Latin America</topic><topic>Male</topic><topic>Maternal health services</topic><topic>Middle Aged</topic><topic>Midwives</topic><topic>Mortality</topic><topic>Neonates</topic><topic>Patient outcomes</topic><topic>Practice Patterns, Physicians' - statistics & numerical data</topic><topic>Pregnancy</topic><topic>Pregnancy Complications - drug therapy</topic><topic>Premature birth</topic><topic>Premature Birth - drug therapy</topic><topic>Prenatal Care - methods</topic><topic>Prevention</topic><topic>Prospective Studies</topic><topic>Reproduction</topic><topic>Reproductive health</topic><topic>Respiratory Distress Syndrome, Newborn - prevention & control</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aleman, Alicia</creatorcontrib><creatorcontrib>Cafferata, Maria L</creatorcontrib><creatorcontrib>Gibbons, Luz</creatorcontrib><creatorcontrib>Althabe, Fernando</creatorcontrib><creatorcontrib>Ortiz, Jose</creatorcontrib><creatorcontrib>Sandoval, Xochitl</creatorcontrib><creatorcontrib>Padilla-Raygoza, Nicolás</creatorcontrib><creatorcontrib>Belizán, José M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Reproductive health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aleman, Alicia</au><au>Cafferata, Maria L</au><au>Gibbons, Luz</au><au>Althabe, Fernando</au><au>Ortiz, Jose</au><au>Sandoval, Xochitl</au><au>Padilla-Raygoza, Nicolás</au><au>Belizán, José M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of antenatal corticosteroids for preterm birth in Latin America: providers knowledge, attitudes and practices</atitle><jtitle>Reproductive health</jtitle><addtitle>Reprod Health</addtitle><date>2013-01-29</date><risdate>2013</risdate><volume>10</volume><issue>1</issue><spage>4</spage><epage>4</epage><pages>4-4</pages><artnum>4</artnum><issn>1742-4755</issn><eissn>1742-4755</eissn><abstract>Antenatal corticosteroids administered to women at risk of preterm birth is an intervention which has been proved to reduce the risk of respiratory distress syndrome, intraventricular hemorrhage, and neonatal mortality. There is a significant gap in the literature regarding the prevalence of the use of antenatal corticosteroids in Latin American countries and the attitudes and opinions of providers regarding this practice. The aim of this study was to assess the knowledge, attitudes and practices of health care providers regarding the use of antenatal corticosteroids in women at risk of preterm birth in Latin America.
This was a multicenter, prospective, descriptive study conducted in maternity hospitals in Ecuador, El Salvador, Mexico and Uruguay. Physicians and midwives who provide prenatal care or intrapartum care for women delivering in the selected hospitals were approached using a self-administered questionnaire. Descriptive statistics was used.
The percentage of use of ACT in threatened preterm labour (TPL) reported by providers varies from 70% in Mexico to 97% in Ecuador. However, 60% to 20% of the providers mentioned that they would not use this medication in women at risk and would limit its use when there was a threatened preterm labour. In only one country recommended regimens of antenatal corticosteroids are followed by around 90% of providers whereas in the other three countries recommended regimens are followed by only 21%, 61%, 69% of providers. Around 40% of providers mentioned that they would administer a new dose of corticosteroids again, regardless the patient already receiving an entire regimen. Between 11% and 35% of providers, according to the countries, mentioned that they do not have adequate information on the correct use of this medication.
This study shows that the use of this intervention could be improved by increasing the knowledge of Latin American providers on its indications, benefits, and regimens.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>23360713</pmid><doi>10.1186/1742-4755-10-4</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1742-4755 |
ispartof | Reproductive health, 2013-01, Vol.10 (1), p.4-4, Article 4 |
issn | 1742-4755 1742-4755 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3598882 |
source | Publicly Available Content Database; PubMed Central(OpenAccess) |
subjects | Adult Attitude of Health Personnel Attitudes Clinical Competence corticoids Corticosteroids Dosage and administration Drug Administration Schedule Drug Utilization - statistics & numerical data Drugs Female Glucocorticoids - administration & dosage Glucocorticoids - adverse effects Glucocorticoids - supply & distribution Glucocorticoids - therapeutic use Health aspects Health care industry Hospitals Humans Infant, Newborn Infant, Premature Infants Infants (Premature) Intervention Latin America Male Maternal health services Middle Aged Midwives Mortality Neonates Patient outcomes Practice Patterns, Physicians' - statistics & numerical data Pregnancy Pregnancy Complications - drug therapy Premature birth Premature Birth - drug therapy Prenatal Care - methods Prevention Prospective Studies Reproduction Reproductive health Respiratory Distress Syndrome, Newborn - prevention & control Womens health |
title | Use of antenatal corticosteroids for preterm birth in Latin America: providers knowledge, attitudes and practices |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T23%3A00%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20antenatal%20corticosteroids%20for%20preterm%20birth%20in%20Latin%20America:%20providers%20knowledge,%20attitudes%20and%20practices&rft.jtitle=Reproductive%20health&rft.au=Aleman,%20Alicia&rft.date=2013-01-29&rft.volume=10&rft.issue=1&rft.spage=4&rft.epage=4&rft.pages=4-4&rft.artnum=4&rft.issn=1742-4755&rft.eissn=1742-4755&rft_id=info:doi/10.1186/1742-4755-10-4&rft_dat=%3Cgale_pubme%3EA534693254%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b576t-4f0c27e7c9ec7bf6225f6e45a4480d96d9d832dad9f8a0fd47e817782c5aecc03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1314905785&rft_id=info:pmid/23360713&rft_galeid=A534693254&rfr_iscdi=true |